Natural Product: NPC575058

Natural Product IDNPC575058
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2~{R})-8-[(2~{R})-2,3-dihydroxy-3-methyl-butyl]-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
IUPAC Name (2~{R})-8-[(2~{R})-2,3-dihydroxy-3-methyl-butyl]-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey MCDSHLATEYMKDN-QZTJIDSGSA-N
Standard InCHI InChI=1S/C20H22O6/c1-20(2,25)18(24)9-14-15(22)8-7-13-16(23)10-17(26-19(13)14)11-3-5-12(21)6-4-11/h3-8,17-18,21-22,24-25H,9-10H2,1-2H3/t17-,18-/m1/s1
SMILES CC(C)(O)[C@H](O)CC1=C(O)C=CC2=C1O[C@@H](C1=CC=C(O)C=C1)CC2=O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   358.14 Volume:   363.093
?
Van der Waals volume.
Dense:   0.986 LogP:   2.158
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.247
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.349
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   18.0
TPSA:   107.22
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   4.0 Rings:   3.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.669 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.468 Fsp3:   0.35
MCE-18:   66.111
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.615 Fluc inhibitor:   0.513
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.276
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.121
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.159 Promiscuous compounds:   0.196

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.224 MDCK Permeability:   -4.742
Pgp-inhibitor:   0.088 Pgp-substrate:   0.368
PAMPA:   0.745
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.001 30% Bioavailability (F30%):   0.521
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.797
Plasma Protein Binding (PPB):   89.085% Volume Distribution (VD):   -0.028
Fu: 13.159%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.852
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.999
BSEP inhibitor:   0.653

ADMET: Metabolism

CYP1A2-inhibitor:   0.047 CYP1A2-substrate:   0.204
CYP2C19-inhibitor:   0.002 CYP2C19-substrate:   0.406
CYP2C9-inhibitor:   0.016 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.695 CYP2D6-substrate:   0.877
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.806
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.925
HLM stability:   0.748
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.833 Half-life (T1/2):  1.789

ADMET: Toxicity

hERG Blockers:  0.156 hERG Blockers (10um):  0.448
Human Hepatotoxicity (H-HT):  0.674 Drug-induced Liver Injury (DILI):  0.049
AMES Toxicity:  0.663 Rat Oral Acute Toxicity:  0.45
Maximum Recommended Daily Dose:  0.699 Skin Sensitization:  0.749
Carcinogencity:  0.501 Eye Corrosion:  0.001
Eye Irritation:  0.94 Respiratory Toxicity:  0.12
Drug-induced Neurotoxicity:  0.829 Ototoxicity:  0.474
Hematotoxicity:  0.079 Drug-induced Nephrotoxicity:  0.629
Genotoxicity:  0.893 RPMI-8226 Immunitoxicity:  0.084
A549 Cytotoxicity:  0.284 Hek293 Cytotoxicity:  0.58
BCF:   0.616
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.313
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.597
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.009
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14009 Brosimum acutifolium Species Moraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO14009 Brosimum acutifolium Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14009 Brosimum acutifolium Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC575058 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7069 Intermediate Similarity NPC164980
0.7031 Intermediate Similarity NPC479214
0.6515 Remote Similarity NPC479211
0.6418 Remote Similarity NPC479213
0.6232 Remote Similarity NPC479217
0.6212 Remote Similarity NPC36275
0.5873 Remote Similarity NPC150408
0.5857 Remote Similarity NPC479215
0.5781 Remote Similarity NPC149026
0.5775 Remote Similarity NPC479212
0.5714 Remote Similarity NPC480991
0.5634 Remote Similarity NPC477958
0.5625 Remote Similarity NPC91560
0.5625 Remote Similarity NPC236766
0.5538 Remote Similarity NPC75049
0.5493 Remote Similarity NPC477957
0.5439 Remote Similarity NPC329225
0.5439 Remote Similarity NPC147686
0.5417 Remote Similarity NPC479221
0.5205 Remote Similarity NPC479207
0.5167 Remote Similarity NPC603284
0.5152 Remote Similarity NPC107572
0.5152 Remote Similarity NPC472580
0.5152 Remote Similarity NPC32739
0.5135 Remote Similarity NPC479218
0.5082 Remote Similarity NPC167624
0.5082 Remote Similarity NPC166482
0.507 Remote Similarity NPC473015

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC575058 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5439 Remote Similarity NPD1549 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data